Bellaire, TX, United States of America

Kerstin Menander

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 2.4

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2014-2021

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Kerstin Menander

Introduction

Kerstin Menander, an accomplished inventor based in Bellaire, TX, has made significant strides in the field of biomedicine. With a total of three patents to her name, she has focused her research on the identification of biomarkers that are crucial in predicting responses to cancer therapies. Her work showcases the integration of innovation and science in addressing complex health challenges.

Latest Patents

Among Kerstin Menander's latest patents are groundbreaking inventions related to P53 biomarkers. Her patents detail the identification of p53 biomarker profiles that predict responses in patients with hyperproliferative diseases like cancer to specific therapies. These innovations also include methods for treating such patients using anti-hyperproliferative disease gene therapy, offering new hope in the fight against cancer.

Career Highlights

Throughout her career, Kerstin has gained valuable experience working with notable organizations such as Multivir Inc. and the University of South Florida. Her work at these institutions has enabled her to collaborate with leading researchers and contribute to pioneering advancements in biomedical research.

Collaborations

Kerstin's collaborative efforts have been impactful, particularly with her coworkers Robert E Sobol and Scott Antonia. Together, they have worked on various projects and have combined their expertise to further the understanding of cancer therapies and biomarker research. Their joint efforts have played a critical role in advancing therapeutic strategies for patients with hyperproliferative diseases.

Conclusion

The contributions of Kerstin Menander highlight the vital intersection of innovation and health sciences. Her patented inventions in P53 biomarker profiling are paving the way for more effective cancer treatments. As she continues her research and collaboration, the potential for positive impacts on patient outcomes remains significant in the evolving landscape of biomedical innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…